


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
GEHC
GE HealthCare Technologie
$82.63
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
Risk Analysis

Investors losing their confidence
GEHC Price Performance
$85.04 (-2.83%)
$75.61 (+9.28%)
$78.71 (+4.98%)
$92.67 (-10.83%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow
![]()
GEHC Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
GEHC Street Sentiment is bullish and have positive views on the near-term outlook
GEHC has Low risk level
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Recent Upgrades and Downgrades
BUY
Date
Action
Rating
Firm
Jan 30, 2026
Reiterate
his Buy
Goldman Sachs
Dec 12, 2025
Reiterate
Buy
Jefferies
Dec 12, 2025
Reiterate
Neutral
Citigroup
Nov 21, 2025
Reiterate
Buy
BTIG
Oct 30, 2025
Reiterate
Overweight
Wells Fargo
What is GEHC current stock price?
What are GEHC stock strengths?
What is GEHC Risk Level?
What is GEHC market cap and volume?
What is GEHC current Stock IQ?
Should I buy GEHC stock right now?
Is GEHC a Strong Buy right now?
What does a 'Strong Buy' rating mean for GEHC?
What does a 'Strong Sell' rating mean for GEHC?
What factors influence GEHC's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
GEHC
GE HealthCare Technologie
Current Price
$82.63

GEHC Price Performance
$85.04 (-2.83%)
$75.61 (+9.28%)
$78.71 (+4.98%)
$92.67 (-10.83%)
GEHC Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow
![]()
GEHC Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
GEHC Street Sentiment is bullish and have positive views on the near-term outlook
GEHC has Low risk level
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Overall Wall Street Rating
BUY
Jan 30, 2026
Reiterate
his Buy
Goldman Sachs
Dec 12, 2025
Reiterate
Buy
Jefferies
Dec 12, 2025
Reiterate
Neutral
Citigroup
Nov 21, 2025
Reiterate
Buy
BTIG
Oct 30, 2025
Reiterate
Overweight
Wells Fargo
GEHC Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
Risk Analysis

Investors losing their confidence
GEHC Latest Analysis
GE HealthCare expects 8–12% EPS growth and $1.7B free cash flow in 2026 as new products ramp.
Wed Feb 4, 2026
GE HealthCare Beats Earnings But Margin Pressure Tariff Costs Could Weigh On Profitability. ) on Wednesday reported adjusted earnings of $1.44 per share .The global health care solutions provider reported sales of $5.69 billion beating the consensus of $5.61 billion.Revenue growth of 7.1% including of 4.8% was driven by Pharmaceutical Diagnostics (PDx) Imaging and Advanced Visualization Solutions (AVS) with overall strength in the United States and Europe the Middle East and Africa (EMEA).Presi
Wed Feb 4, 2026
GE HealthCare Q4 Earnings and Revenues Beat Estimates Net Margin Falls. GEHC tops Q4 EPS and revenue estimates as Imaging and PDx drive growth but net margin slides on tariffs and product mix.
Wed Feb 4, 2026
GE HealthCare Technologies Stock Climbs 5% Over Revenue Growth In Q4 . (RTTNews) - Stock of GE HealthCare Technologies Inc. (GEHC) is moving up about 5 percent on Wednesday morning trading over announcement of fourth-quarter financial results reporting total revenues of $5.698 billion compared to $5.319 billion in the previous year.
Wed Feb 4, 2026
Nasdaq 100 Movers: APP GEHC. In early trading on Wednesday shares of GE HealthCare Technologies topped the list of the days best performing components of the Nasdaq 100 index trading up 4.3%. Year to date GE HealthCare Technologies registers a 0.2% gain.And the worst performing Nasdaq 100 component t
Wed Feb 4, 2026
GE HealthCare Technologies (GEHC) Q4 Earnings and Revenues Beat Estimates. GE HealthCare (GEHC) delivered earnings and revenue surprises of 1.00% and 1.87% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Wed Feb 4, 2026
GE HealthCare Technologies beats top-line and bottom-line estimates. initiates FY26 outlook.
Wed Feb 4, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
GEHC Stock trends
GEHC Stock performance
GEHC Stock analysis
GEHC investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.